|
|
|
|
Vol. 18, Issue 8, 3068-3080, August 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*Laboratoire de Physiologie Moléculaire de la Cellule, Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, B-6041 Gosselies, Belgium; and
University of Regensburg, Cell Biology and Plant Physiology, 93040 Regensburg, Germany
Submitted March 2, 2007;
Revised May 18, 2007;
Accepted May 29, 2007
Monitoring Editor: Thomas Sommer
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
30,000 per µm2 (Jacobson et al., 2007
10–200 nm in diameter) that are formed by the dynamic assembly of sphingolipids with sterols (Simons and Ikonen, 1997
The yeast general amino acid permease Gap1 (Grenson et al., 1970
) is an attractive system for investigating the mechanisms controlling the membrane trafficking of cell surface proteins. The fate of the Gap1 permease is regulated according to the nitrogen supply conditions of the medium (Magasanik and Kaiser, 2002
; Haguenauer-Tsapis and André, 2004
). When cells grow on a nitrogen-poor medium, the GAP1 gene is highly expressed (Jauniaux and Grenson, 1990
) and the Gap1 protein accumulates at the plasma membrane in a highly active and stable form (Grenson, 1983
; De Craene et al., 2001
). Endocytosis of Gap1 is triggered when a good nitrogen source such as ammonium or an excess of amino acids is added to the medium (Hein et al., 1995
; Stanbrough and Magasanik, 1995
; Springael and André, 1998
). The presence of these nitrogenous compounds probably inactivates Npr1, a protein kinase essential to protection of Gap1 against ubiquitination (De Craene et al., 2001
) and under the control of the TOR signaling pathway (Schmidt et al., 1998
). Endocytosis of Gap1 requires prior ubiquitination on two lysine residues present in the N-terminal tail of the permease, at positions 9 and 16 (Springael and André, 1998
; Soetens et al., 2001
), and closer analysis of this process has revealed that the protein undergoes polyubiquitination with K63-type chains (Springael et al., 1999
). The ubiquitination of Gap1 requires the Rsp5 (Npi1) ubiquitin ligase (Hein et al., 1995
; Springael and André, 1998
) acting together with the Bul1 and Bul2 factors (Yashiroda et al., 1996
; Helliwell et al., 2001
; Soetens et al., 2001
). Delivery of internalized Gap1 into the lumen of the vacuole where the protein is degraded requires its prior sorting into the multivesicular body (MVB) pathway (Nikko et al., 2003
), and defects at this level lead either to accumulation of the permease at the late endosome or to effective recycling to the plasma membrane by passage through the Golgi.
In a previous article, we reported that Gap1 fractionates with DRMs when it is present at the plasma membrane (Lauwers and André, 2006
), and we proposed that this may be true for all cell surface proteins. Newly synthesized Gap1 acquires detergent insolubility at the Golgi level, and this property is preserved until the protein present at the cell surface is internalized by endocytosis. Moreover, sphingolipid neosynthesis seems essential to the accumulation of newly synthesized Gap1 at the cell surface. When this biosynthesis is defective, neosynthesized Gap1 is targeted to the endosome/vacuolar degradation pathway (Lauwers and André, 2006
), as for Pma1 (Bagnat et al., 2001
; Gaigg et al., 2005
). In the present study, we have further investigated the role of sphingolipids in controlling the intrinsic function, ubiquitination, and membrane trafficking of the yeast Gap1 protein. We have also tested a prediction of the lipid shell model, i.e., that ongoing sphingolipid biosynthesis should be mostly important during Gap1 biogenesis and secretion, and less after Gap1 has integrated the plasma membrane.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Yeast–Cell Extracts and Western Blotting
Total protein extracts were obtained as described previously (Hein et al., 1995
). Proteins were resuspended in sample buffer and incubated for 10 min at 37°C before SDS-polyacrylamide gel electrophoresis (PAGE). After transfer to a nitrocellulose membrane (Schleicher & Schüll, Dassel, Germany), the proteins were probed with polyclonal antibodies raised against Gap1 or Pma1 (De Craene et al., 2001
). Primary antibodies were detected with horseradish-peroxidase-conjugated anti-rabbit secondary antibody (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) followed by enhanced chemiluminescence (Roche Diagnostics, Mannheim, Germany).
Limited Proteolysis
The experiment was performed essentially as described previously (Gong and Chang, 2001
). Cells were lysed with glass beads in 200 µl buffer (50 mM HEPES pH 7.5, NaCl 300 mM). A total membrane fraction was generated by centrifugation at 100,000 x g for 60 min in a SW55 Ti rotor (Beckman Coulter, Fullerton, CA). Membranes were resuspended in buffer and incubated at a protein concentration of 0.5 mg/ml at 30°C and at a trypsin:protein ratio of 1:5. Samples were collected after 0, 0.5, 2, 5, 10, and 20 min, and the reaction was stopped by adding trypsin inhibitor. A control reaction was run for 20 min in the absence of trypsin. Proteins were precipitated by adding 10% trichloroacetic acid (TCA) and Gap1 was analyzed by Western blotting with anti-Gap1 antibodies as described previously. N-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin and trypsin inhibitor type I-S from soybean were purchased from Sigma-Aldrich (Schnelldorf, Germany).
Subcellular Fractionation
Fractionation was performed as described previously (Bagnat et al., 2001
; Lauwers and André, 2006
). Cells were lysed with glass beads in buffer L (25 mM Tris, pH 8, and 2.5 mM EDTA) supplemented with a cocktail of protease inhibitors (Roche Diagnostics) and 25 mM N-ethylmaleimide (NEM). The cleared lysate was centrifuged at 20,000 x g for 30 min in a SW55 Ti rotor (Beckman Coulter), and the pellet was then resuspended in 20% glycerol in buffer B (10 mM Tris, pH7.4, 0.2 mM EDTA, and 0.2 mM dithiothreitol). The samples (500 µl) were loaded on top of a sucrose step gradient (0.5 ml, 53%; 1 ml, 43%; in buffer B) and centrifuged at 100,000 x g for 2 h in a Beckman SW55 Ti rotor. After centrifugation, six fractions of equal volume were collected from the top of the gradient, and the distribution of Pma1 and Gap1 was analyzed by Western blotting.
Fluorescence Microscopy
Cells transformed with the pEL003 or pEL025 plasmid were laid down on a thin layer of 1% agarose and viewed with a Nikon Eclipse E600 microscope equipped with appropriate fluorescence light filter sets. Images were captured with a Nikon DXM1200 digital camera and processed with Adobe Photoshop CS (Adobe Systems, Mountain View, CA).
Detergent-resistant Membrane Isolation
DRMs were isolated as described previously (Lauwers and André, 2006
). Cells were harvested by filtration and lysed in TNE buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 5 mM EDTA) supplemented with a cocktail of protease inhibitors (complete protease inhibitors; Roche Diagnostics) and 25 mM NEM. The cleared lysate was incubated with 1% Triton X-100 for 30 min on ice. Lysate (250 µl) was adjusted to 40% iodixanol by adding 500 µl of Optiprep (Axis-Shield, Oslo, Norway), and it was loaded at the bottom of a two-step gradient (1200 µl of 30% iodixanol in TNXE [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, and 0.1% Triton X-100], and 200 µl TNXE). The gradient was centrifuged at 46,000 rpm for 120 min at 4°C in a Beckman Sw55Ti rotor. Six fractions of equal volume were collected from the top of the gradient, and the proteins were precipitated by incubation with 10% TCA for 30 min. The precipitates were dissolved in 40 µl of 1 M Tris base plus 40 µl of 2X sample buffer (100 mM Tris-HCl, pH 6.8, 4 mM EDTA, 4% SDS, 20% glycerol, and 0.02% bromphenol blue) supplemented with 2% 2-mercaptoethanol. The samples were heated at 37°C for 15 min, and then they were analyzed by Western blotting for the presence of Gap1 and Pma1. Fractions 1–3 were pooled (R, Triton X-100–resistant membranes), as were fractions 4–6 (S, Triton X-100–soluble membranes).
Confocal Microscopy
Confocal sections were scanned using a LSM510-Meta confocal microscope (Zeiss, Jena, Germany). Double-labeled cells (Gap1-green fluorescent protein [GFP] and Sur7-monomeric red fluorescent protein [mRFP]) were sequentially scanned to avoid any cross talk of fluorescence channels. Living cells were immobilized by a thin film (
0.5 mm) of 1% agarose and observed.
| RESULTS |
|---|
|
|
|---|
double mutant cells (Figure 1A). Marked stabilization of Gap1 was also observed in lcb1-100 cells additionally deficient in Rsp5 (Npi1), the ubiquitin ligase required for ubiquitination and endocytosis of Gap1 (Hein et al., 1995
strain (Figure 1A). Hence, when SL biosynthesis is impaired, newly synthesized Gap1 protein seems to be delivered to the plasma membrane before undergoing rapid ubiquitin-dependent down-regulation. These observations were confirmed by examining the localization of a functional Gap1–GFP fusion protein (Figure 1B). When wild-type or end3
cells carrying a plasmid encoding this Gap1–GFP construct were grown in glutamine- and ammonium-containing medium and then transferred to proline-containing medium at either 24 or 37°C for 2 h, fluorescence was observed at the cell surface regardless of the temperature, reflecting accumulation of Gap1–GFP at the plasma membrane. In lcb1-100 cells, in contrast, whereas Gap1-GFP localized correctly to the cell surface when produced at 24°C, only a weak, intracellular fluorescent signal was detected when the permease was induced at 37°C. In the lcb1-100 end3
strain, however, Gap1–GFP neosynthesized at 37°C clearly labeled the cell surface (Figure 1B). This observation corroborates the results of immunoblot analysis (Figure 1A), and it confirms that the permease produced in the absence of SL biosynthesis is delivered to the plasma membrane before being efficiently endocytosed. This conclusion is also supported by the results of a subcellular fractionation experiment, where after a 2-h shift of the lcb1-100 end3
double mutant to proline medium at 37°C,
60% of the Gap1 protein was found with the plasma membrane marker Pma1 in the bottom fractions of a sucrose density gradient (data not shown).
|
-pheromone receptor, and this defect can be overcome by the addition of DHS or PHS. Because these precursors do not need to be further metabolized to restore endocytosis, it seems that sphingoid bases themselves are required for endocytic internalization (Zanolari et al., 2000
lac1
mutant cells devoid of ceramide synthase activity (Schorling et al., 2001
lac1
cells, however, Gap1 transport activity was dramatically reduced (Figure 1D), indicating that SL biosynthesis at least up to the ceramide level is required for the accumulation of Gap1 at the plasma membrane, as it has been reported for the plasma membrane ATPase Pma1 (Gaigg et al., 2005
The Gap1 Permease Produced in the Absence of Sphingolipid Neosynthesis Does Not Acquire Detergent Insolubility
The accumulation of Gap1 at the plasma membrane in the lcb1-100 end3
strain enabled us to examine the properties of the permease that is synthesized and delivered to the plasma membrane in the absence of SL neosynthesis. We first examined whether this Gap1 fractionates with DRMs. When Gap1 synthesis was induced in wild-type cells by shifting them to a proline-containing medium at 37°C, the permease was found to fractionate with DRMs (Figure 2A). In contrast, when the permease was similarly induced at 37°C in lcb1-100 end3
double mutant cells, a strong Gap1 signal was detected in the fractions corresponding to detergent-soluble membranes. The residual amount of Gap1 protein induced under the same conditions in the lcb1-100 cells was also found to be soluble in Triton X-100 (Figure 2A). Hence, Gap1 produced in the absence of SL biogenesis, although stabilized at the plasma membrane, fails to fractionate with DRMs. This is surprising, because SLs are very stable in yeast (Dickson and Lester, 2002
) and should thus be abundant in the plasma membrane, even if their neosynthesis has been blocked for 2 h, as in the above-mentioned experiment. Accordingly, under the same conditions the proton ATPase Pma1 remained insoluble in Triton X-100 (Figure 2A), indicating that SL-enriched domains were still present at the cell surface but that neosynthesized Gap1 failed to integrate into them. We have previously reported that the ability of Gap1 to associate with DRMs in lcb1-100 cells can be restored by addition of the SL precursor DHS during Gap1 synthesis and secretion (Lauwers and André, 2006
). Accordingly, when DHS was present in the growth medium during induction of Gap1 synthesis at 37°C, Gap1 stability and insolubility in Triton X-100 was completely restored in lcb1-100 cells, and the permease also regained full detergent insolubility in lcb1-100 end3
double-mutant cells (Figure 2A).
|
double mutant enabled us for the first time to maintain the Gap1 permease at the plasma membrane but outside SL-enriched domains. We were thus able to test whether the association of Gap1 with these domains is important for the transport activity of the protein (Figure 2B). When Gap1 synthesis was induced for 2 h in wild-type or end3
cells at 24 or 37°C, citrulline uptake activity was found to develop regardless of the temperature, reflecting Gap1 accumulation at the plasma membrane. As expected, no Gap1 activity was observed in lcb1-100 cells at the restrictive temperature. Strikingly, the detergent-soluble permease accumulated at the plasma membrane in lcb1-100 end3
cells at 37°C proved inactive, whereas high permease activity was restored in this double mutant by addition of DHS in the course of Gap1 synthesis (Figure 2B). These results reveal that Gap1 protein synthesized in the absence of SL biosynthesis and blocked at the plasma membrane not only fails to integrate into SL-enriched domains but also is intrinsically inactive. Interestingly, the detergent-soluble Gap1–GFP permease accumulated at the plasma membrane in lcb1-100 end3
cells at 37°C also showed a marked increase in trypsin sensitivity compared with end3
cells (Figure 2C), indicating that segregation of Gap1 outside SL-enriched domains leads to a greater accessibility of the protein to proteases. Similarly, a variant form of Gap1 that is resistant to ubiquitination and endocytosis (see below) was much more susceptible to limited trypsinolysis when synthesized at 37°C in the lcb1-100 mutant than in wild-type cells (Figure 2D). Because the anti-Gap1 antibodies used in this experiment were raised against the amino-terminal part of Gap1 (residues 1–90) (De Craene et al., 2001
Down-Regulation of Gap1 Produced in the Absence of Sphingolipid Biosynthesis Involves Its Ubiquitination on Nonclassical Membrane-proximal Lysines
As shown above, the inactive and detergent-soluble Gap1 protein having reached the plasma membrane under conditions preventing SL biosynthesis is rapidly down-regulated in a ubiquitin-dependent manner (Figure 1A). It is noteworthy that this down-regulation occurs although the medium contains only proline as a nitrogen source, i.e., under nitrogen-supply conditions that normally promote stable accumulation of Gap1 at the cell surface, this being dependent on Npr1 kinase (De Craene et al., 2001
). Gap1 down-regulation typically occurs when a good nitrogen source such as ammonium is added to the culture medium, conditions proposed to inactivate Npr1 (Schmidt et al., 1998
). It thus seems that the control exerted by Npr1 and protecting Gap1 against down-regulation on poor nitrogen media is defective when Gap1 has been produced in the absence of SL biosynthesis.
In wild-type cells, down-regulation of Gap1 caused by the transfer of cells to optimal nitrogen supply conditions involves ubiquitination of the permease on two ubiquitin-acceptor lysines, K9 and K16, located in its amino-terminal tail. A variant permease Gap1K9,16R, where both lysines have been replaced with arginines, is resistant to ubiquitination and endocytosis, and it is thus protected against degradation (Soetens et al., 2001
). We sought to determine whether this Gap1K9,16R variant is also resistant to degradation in cells defective in SL biosynthesis. Surprisingly, Gap1K9,16R synthesized in lcb1-100 cells behaved like the native Gap1 protein, i.e., a strong Gap1 signal was immunodetected when the permease was produced at 24°C, but the mutant permease failed to accumulate at the plasma membrane (data not shown) and in immunoblots at the restrictive temperature of 37°C (Figure 3A), reflecting its down-regulation. Because the Rsp5 ubiquitin ligase is nevertheless required for degradation of Gap1 in lcb1-100 cells at 37°C (Figure 1A), we reasoned that other lysines of the permease are probably ubiquitinated. We thus constructed a mutant permease, Gap19KR, with all nine lysine residues of the N-terminal tail replaced with arginines. When produced in wild-type cells at 24 or 37°C, the Gap19KR protein was normally secreted to the plasma membrane, and it was active at both temperatures (Figure 3, B–D). In the lcb1-100 mutant at the restrictive temperature of 37°C, in contrast to the native permease and the Gap1K9,16R variant, the newly synthesized Gap19KR protein seemed stable (Figure 3E). Furthermore, Gap19KR produced in wild-type or lcb1-100 cells was found at the plasma membrane regardless of the temperature, as indicated by visualization of a functional Gap19KR–GFP fusion protein at the cell surface (Figure 3B) and by cofractionation of Gap19KR with the plasma membrane marker Pma1 in a sucrose density gradient (Figure 3C). Yet the cell surface-located Gap19KR proved inactive in the lcb1-100 mutant at 37°C (Figure 3D), like the native Gap1 permease trapped at the plasma membrane in the lcb1-100 end3
mutant (Figure 2B). This again argues for the association of Gap1 with SL-enriched domains being crucial to the transport activity of the permease.
|
Sphingolipid Neosynthesis Is Specifically Required during Gap1 Production
The above-mentioned data show that arrest of SL neosynthesis during Gap1 production and secretion results in lack of Gap1 activity, increased sensitivity of the permease to trypsinolysis, inability of Gap1 to integrate existing SL-enriched domains (containing other proteins such as Pma1), and unregulated Gap1 down-regulation. We next wondered what would be the effect of an arrest of SL neosynthesis occurring after Gap1 protein has accumulated at the plasma membrane. We started with lcb1-100 cells expressing Gap19KR–GFP and grown at the permissive temperature of 24°C with proline as the sole nitrogen source. Under these conditions, the permease accumulated at the plasma membrane in an active (data not shown) and stable form, and it fractionated largely with DRMs (Figure 4A), as expected. A significant amount of Gap19KR was also detected in the fractions corresponding to detergent-soluble membranes, probably corresponding to permeases en route to the plasma membrane and having not yet integrated SL-enriched domains. Accordingly, this soluble pool of Gap19KR was completely resorbed after permease synthesis was arrested and the cells grown for two more hours (Figure 4A). Gap19KR–GFP production was then blocked, and SL neosynthesis was arrested by transferring the cells to glutamine- and ammonium-containing medium at 37°C. No major change in permease detergent-solubility or activity was observed even 2 h after the shift to the restrictive temperature (Figure 4A; data not shown). Thus, once Gap1 has established its location within SL-enriched domains at the plasma membrane, there is no need for sustained SL neosynthesis to maintain this association, at least during the first hours after Gap1 production. This resembles the behavior of the proton ATPase Pma1, which remains detergent-insoluble even 2 h after arrest of SL neosynthesis (e.g., Figure 2A). We next performed the reverse experiment, preaccumulating Gap19KR at the plasma membrane outside SL-enriched domains and then allowing SL neosynthesis to resume. For this, lcb1-100 mutant cells grown at 24°C were first shifted to proline-containing medium at 37°C to induce synthesis of Gap19KR. As expected, Gap19KR accumulated at the plasma membrane but was inactive (data not shown) and totally soluble in Triton X-100 (Figure 4B). Gap19KR synthesis was then blocked by transferring the cells to glutamine- and ammonium-containing medium, and 30 min later the SL precursor DHS was added to the culture to restore SL biosynthesis. Remarkably, the permease remained excluded from DRMs (Figure 4B) and inactive (data not shown), even 2 h after DHS addition, indicating that a restored SL supply cannot reinstate either the activity of the permease or its association with SL-enriched domains. Together, these results suggest that SL biosynthesis is crucial specifically during synthesis and secretion of the permease. Accordingly, maintenance of this biosynthesis is not required to preserve the properties of Gap1 having reached the plasma membrane, and the defects displayed by Gap1 produced in the absence of SL biosynthesis seem irreversible, i.e., they are not compensated by restoring normal SL biosynthesis. This suggests that the biogenesis of Gap1 is somehow coupled to that of SLs, this being crucial for Gap1 to acquire detergent insolubility, activity, and normal control of its ubiquitination.
|
|
or end3
lcb1-100 mutant cells expressing Gap1–GFP were visualized after a 2-h induction at the restrictive temperature of 37°C (Figure 5B). This result indicates that the homogenous repartition of Gap1 at the plasma membrane is not altered when the permease fails to associate with SL-enriched domains.
The homogeneous distribution of Gap1 at the cell surface is reminiscent of the situation described for the hexose permease Hxt1 (Malinska et al., 2003
). The Gap1 and Hxt1 permeases thus seem to define a third group of yeast plasma membrane proteins, i.e., those that do not specifically segregate into the MCC or MCP. Furthermore, Gap1 plasma membrane repartition is not altered if the permease is produced in the absence of SL biosynthesis.
| DISCUSSION |
|---|
|
|
|---|
As mentioned above, the proposed association of proteins with a lipid shell might also account for their lateral distribution into domains of the plasma membrane (Anderson and Jacobson, 2002
). In yeast, multiple permeases (Can1, Fur4, Tat2) and other membrane proteins (e.g., Sur7) colocalize in discrete patches constituting the MCC, whereas Pma1 is excluded from this compartment and apparently occupies the remaining space of the cell surface, called the MCP (Malinska et al., 2003
; Malinska et al., 2004
; Grossmann et al., 2006
). We have shown in this work that the Gap1 permease is instead homogenously distributed at the plasma membrane and thus displays a lateral segregation profile very similar to that of the Hxt1 hexose transporter (Malinska et al., 2003
). Because all the above-cited proteins fractionate with DRMs (Dupré and Haguenauer-Tsapis, 2003
; Malinska et al., 2003
, 2004
; Umebayashi and Nakano, 2003
; Lauwers and André, 2006
), the question arises of why they segregate differently in the plasma membrane. One possibility is that all these proteins are detergent-insoluble because they are encased in a lipid shell during their biosynthesis and secretion. The lipid composition and structure of these shells, however, could differ substantially according to the protein, conferring specific aggregation properties that would determine protein self-distribution between distinct membrane domains (Figure 6). In support of this view, it is noteworthy that the protein components of the MCP and MCC show distinct lipid requirements. For example, biosynthesis of SLs but not ergosterol is essential to cell surface accumulation of Pma1 (Gaigg et al., 2005
), whereas ergosterol, which is more abundant in the MCC than in the MCP (Grossmann et al., 2007
), is necessary for plasma membrane targeting of Tat2 (Umebayashi and Nakano, 2003
). It has also recently been reported that the patchy distribution of some proteins normally present in the MCC is lost upon membrane depolarization (Grossmann et al., 2007
). This depolarization might affect the conformation of the intrinsic membrane proteins (Patzlaff et al., 2002
) and consequently their association with surrounding lipids and their ability to aggregate preferentially with other proteins.
|
Our data also suggest an important role of SL biogenesis during Gap1 production and secretion for proper control of the permease by ubiquitination. Under normal conditions, Gap1 undergoes ubiquitination on N-terminal lysines at positions 9 and 16 only once the control exerted by the Npr1 kinase has been released, i.e., when a favored nitrogen is added to the medium (De Craene et al., 2001
; Soetens et al., 2001
). In contrast, Gap1 proteins produced in the absence of SL neosynthesis escape this Npr1-dependent control and undergo efficient Rsp5-mediated down-regulation even in cells growing on a poor nitrogen source. Although this down-regulation can rely solely on the classical ubiquitin acceptor lysines 9 and 16 in the N-terminal tail, our data show that three additional lysines of this tail, at positions 76, 87, and 91, can also promote the unregulated down-regulation of Gap1. Under normal conditions of SL biogenesis, these three residues, located close to the membrane (Figure 3F), have so far not been implicated in nitrogen-regulated control of Gap1 ubiquitination. Yet in two global analyses of ubiquitin conjugates in yeast, Gap1 was found to be ubiquitinated at lysine 76 (Hitchcock et al., 2003
; Peng et al., 2003
). In both studies, yeast cells were grown on a standard rich medium, conditions under which GAP1 gene transcription is largely repressed and Gap1 permease synthesized to a limited level is directly sorted from the Golgi to the endosome/vacuolar degradation pathway without passing through the plasma membrane (Magasanik and Kaiser, 2002
). It is thus possible that ubiquitination of Gap1 at position 76 might also occur under particular environmental conditions, even when SL biogenesis occurs normally. In one of the above-cited proteomics studies, the analyzed cells contained a mutation impairing degradation of protein substrates of the ER-associated degradation pathway (Hitchcock et al., 2003
), raising the possibility of a role of lysine 76 (and possibly lysines 87 and 91) in ubiquitination of Gap1 at ER level. Whatever the membrane compartment where ubiquitination of neosynthesized Gap1 takes place when SL biogenesis is defective, our results suggest that this modification is involved in a quality-control mechanism that ensures removal of misfolded permeases from the plasma membrane. Accordingly, Gap1 produced in the absence of SL biosynthesis is more susceptible to trypsinolysis, suggesting that the permease conformation is altered (Figure 2, C and D). SLs might thus act as chaperones to shape newly synthesized Gap1 into its correct conformation, similarly to the role of phosphatidylethanolamine in proper folding of the
-aminobutyric acid permease GabP of Escherichia coli (Zhang et al., 2005
). Alternatively, a more direct role of SLs in protecting Gap1 against ubiquitination could also be considered. Although mammalian SLs are known to reside mainly in the exoplasmic leaflet of the plasma membrane (Holthuis et al., 2001
),
20% of them are found in the cytoplasmic leaflet (Boon and Smith, 2002
). Even if no data are currently available about the distribution of SLs over the two leaflets of the yeast plasma membrane (van Meer and Holthuis, 2000
), it is thus conceivable that at least a small fraction of these lipids face the cytoplasm, in particular if they are forming a shell around transmembrane proteins. Because the cytosolic lysines 76, 87, and 91 of Gap1 are close to the membrane (Figure 3F), they might be part of the region containing the SL head groups and thus be inaccessible to posttranslational modifications. When Gap1 is not associated with SLs, these lysines would in contrast be exposed and targeted by the Rsp5 ubiquitin ligase, promoting degradation of the permease. Although this unregulated process might be considered a fortuitous consequence of impaired SL biogenesis, it might also be regarded as an actual quality-control mechanism ensuring that only Gap1 proteins correctly associated with SLs (and thus in an active conformation) can be stabilized at the cell surface.
SL biogenesis is also important for plasma membrane accumulation of several other proteins, including the Pma1 H+ ATPase (Bagnat et al., 2001
; Eisenkolb et al., 2002
; Wang and Chang, 2002
; Gaigg et al., 2005
). In this case, a role of SLs in protein oligomerization has also been proposed (Wang and Chang, 2002
). Furthermore, a mutant form of Pma1 (Pma1-10) that fails to associate with DRMs is normally targeted to the cell surface, but it undergoes rapid and ubiquitin-dependent down-regulation (Wang and Chang, 2002
; Liu and Chang, 2006
). Cell surface delivery of several other plasma membrane proteins is also defective in lcb1-100 cells (Sutterlin et al., 1997
; Hearn et al., 2003
; Dupré and Haguenauer-Tsapis, 2003
), although sphingoid base synthesis is not a general requirement for trafficking along the secretory pathway (Sutterlin et al., 1997
). In the Tat2 tryptophan permease, ergosterol is essential to targeting and accumulation at the plasma membrane (Umebayashi and Nakano, 2003
). The picture emerging from these studies and the present work points to a crucial role of the lipid microenvironment of plasma membrane proteins in determining their intrinsic conformation and function, controlling their ubiquitination, and probably in determining their lateral distribution between distinct membrane domains.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Bruno André (bran{at}ulb.ac.be).
Abbreviations used: DHS, dihydrosphingosine; DRM, detergent-resistant membrane; PHS, phytosphingosine; SL, sphingolipid.
| REFERENCES |
|---|
|
|
|---|
Babst, M. (2005). A protein's final ESCRT. Traffic 6, 2–9.[CrossRef][Medline]
Bagnat, M., Chang, A., and Simons, K. (2001). Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol. Biol. Cell 12, 4129–4138.
Bagnat, M., Keränen, S., Shevchenko, A., Shevchenko, A., and Simons, K. (2000). Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. USA 97, 3254–3259.
Bénédetti, H., Raths, S., Crausaz, F., and Riezman, H. (1994). The END3 gene encodes a protein that is required for the internalization step of endocytosis and for actin cytoskeleton organization in yeast. Mol. Biol. Cell 5, 1023–1037.[Abstract]
Bilodeau, P. S., Winistorfer, S. C., Kearney, W. R., Robertson, A. D., and Piper, R. C. (2003). Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency of sorting ubiquitinated proteins at the endosome. J. Cell Biol 163, 237.
Bonneaud, N., Ozier-Kalogeropoulos, O., Li, G. Y., Labouesse, M., Minvielle-Sebastia, L., and Lacroute, F. (1991). A family of low and high copy replicative, integrative and single-stranded S. cerevisiae/E. coli shuttle vectors. Yeast 7, 609–615.[CrossRef][Medline]
Boon, J. M., and Smith, B. D. (2002). Chemical control of phospholipid distribution across bilayer membranes. Med. Res. Rev 22, 251–281.[CrossRef][Medline]
Brown, D. A., and London, E. (1998). Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol 164, 103–114.[CrossRef][Medline]
De Craene, J.-O., Soetens, O., and André, B. (2001). The Npr1 kinase controls biosynthetic and endocytic sorting of the yeast Gap1 permease. J. Biol. Chem 276, 43939–43948.
Dickson, R. C., and Lester, R. L. (2002). Sphingolipid functions in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1583, 13–25.[Medline]
Dupré, S., and Haguenauer-Tsapis, R. (2003). Raft partitioning of the yeast uracil permease during trafficking along the endocytic pathway. Traffic 4, 83–96.[CrossRef][Medline]
Eisenkolb, M., Zenzmaier, C., Leitner, E., and Schneiter, R. (2002). A specific structural requirement for ergosterol in long-chain fatty acid synthesis mutants important for maintaining raft domains in yeast. Mol. Biol. Cell 13, 4414–4428.
Fantini, J. (2003). How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains. CMLS 60, 1027–1032.[Medline]
Futerman, A. H., and Riezman, H. (2005). The ins and outs of sphingolipid synthesis. Trends Cell Biol 15, 312–318.[CrossRef][Medline]
Gaigg, B., Timischl, B., Corbino, L., and Schneiter, R. (2005). Synthesis of sphingolipids with very long chain fatty acids but not ergosterol is required for routing of newly synthesized plasma membrane ATPase to the cell surface of yeast. J. Biol. Chem 280, 22515–22522.